Behavioral, neurochemical and neuroimmune features of RasGEF1b deficient mice

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Feb 8:129:110908. doi: 10.1016/j.pnpbp.2023.110908. Epub 2023 Dec 2.

Abstract

The factor RasGEF1b is a Ras guanine exchange factor involved in immune responses. Studies have also implicated RasGEF1b in the CNS development. It is still limited the understanding of the role of RasGEF1b in CNS functioning. Using RasGEF1b deficient mice (RasGEF1b-cKO), we investigated the impact of this gene deletion in behavior, cognition, brain neurochemistry and microglia morphology. We showed that RasGEF1b-cKO mice display spontaneous hyperlocomotion and anhedonia. RasGEF1b-cKO mice also exhibited compulsive-like behavior that was restored after acute treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (5 mg/kg). A down-regulation of mRNA of dopamine receptor (Drd1, Drd2, Drd4 and Drd5) and serotonin receptor genes (5Htr1a, 5Htr1b and 5Htr1d) was observed in hippocampus of RasGEF1b-cKO mice. These mice also had reduction of Drd1 and Drd2 in prefrontal cortex and 5Htr1d in striatum. In addition, morphological alterations were observed in RasGEF1b deficient microglia along with decreased levels of hippocampal BDNF. We provided original evidence that the deletion of RasGEF1b leads to unique behavioral features, implicating this factor in CNS functioning.

Keywords: Anhedonia; Compulsive-like behavior; Hyperactivity; Microglia; RasGEF1b.

MeSH terms

  • Animals
  • Brain*
  • Cognition
  • Fluoxetine / pharmacology
  • Mice
  • Prefrontal Cortex
  • Receptors, Dopamine D5
  • Selective Serotonin Reuptake Inhibitors*

Substances

  • Drd5 protein, mouse
  • Fluoxetine
  • Receptors, Dopamine D5
  • Selective Serotonin Reuptake Inhibitors
  • RasGEF1B protein, mouse